VitaNova Life Sciences (VNOV) Annual Balance Sheets

Annual · GAAP · USD millions
Access VNOV quarterly Balance Sheets →
Examining balance sheet movements between VitaNova Life Sciences and Apr 30 2022 reveals how Apr 30 2026 adjusts its asset composition and liability profile.
Annual Report, GAAP in USD millions
ITEM
(Apr 30 2026)
(Apr 30 2025) (Apr 30 2024) (Apr 30 2023) (Apr 30 2022)
Assets
Cash & cash equivalent1.60
Cash & Short-term Investments1.00
Accounts receivable0.73
Notes Receivable, Current0.00
Inventories0.11
Other Current Assets0.00
Total Current Assets2.43
Tax Assets, Noncurrent0.02
Total Assets2.45
Liabilities
Accounts Payable0.21
Accrued Liabilities, Current0.08
Taxes Payable0.11
Total Current Liabilities0.40
Total Long-term Debt0.00
Total Liabilities0.40
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1.03
Retained Earnings / Accumulated Deficit0.83
Common Stockholder's Equity2.05
Total Stockholder's Equity2.05
Liabilities & Stockholder's Equity2.45
4 historic quarters locked

Sign in to unlock the full VitaNova Life Sciences balance sheet history.

About Vitanova Life Sciences Corp Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001683168-26-005837

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License